Vir Biotechnology, Inc. (NASDAQ: VIR) is navigating the biotechnology landscape with a focus on the development of therapies aimed at combating serious infectious diseases. Based in..
uniQure N.V. (NASDAQ: QURE), a Dutch biotechnology firm, is making waves in the healthcare sector with its innovative gene therapies targeting rare and debilitating diseases. With..
Sionna Therapeutics, Inc. (NASDAQ: SION) has captured the attention of investors due to its impressive potential upside of 414.71%, as indicated by analyst ratings. Specializing in..
SI-BONE, Inc. (NASDAQ: SIBN) stands out in the healthcare sector, specifically within the medical devices industry, for its innovative procedural solutions focused on bone stabilization and..
For investors eyeing the biotechnology sector, Dianthus Therapeutics, Inc. (NASDAQ: DNTH) presents a fascinating opportunity. With a market cap of $4.07 billion, this New York-based company..
Nuvation Bio Inc. (NASDAQ: NUVB), a burgeoning player in the biotechnology sector, presents a compelling case for investors eyeing the healthcare space. With a market capitalization..
For investors with an eye on the healthcare sector, particularly biotechnology, Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) presents an intriguing proposition. With its focus on developing cutting-edge..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents a compelling, albeit high-risk, opportunity for investors within the biopharmaceutical sector. With a market capitalization of $192.73 million and a..
ArriVent BioPharma, Inc. (NASDAQ: AVBP), a clinical-stage biopharmaceutical company, is making waves in the biotechnology industry with its innovative approach to tackling unmet medical needs in..
Replimune Group, Inc. (REPL), a pioneering force in oncolytic immunotherapy, is attracting significant investor interest with its potential upside of 65.96%, according to recent analyst ratings...
For investors with an eye on the healthcare sector, particularly those interested in biotechnology, Trevi Therapeutics, Inc. (NASDAQ: TRVI) presents an intriguing proposition. With a market..
Zymeworks Inc. (NASDAQ: ZYME), a prominent player in the biotechnology sector, has captured the attention of investors with its impressive potential for upside and the unanimous..
Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of investors in the biotechnology sector with its innovative approach to cancer treatment. As a clinical-stage biopharmaceutical..
iRadimed Corporation (NASDAQ: IRMD), a prominent player in the medical devices sector, offers a compelling investment proposition with its strong growth potential. Based in Orlando, Florida,..
Oculis Holding AG (OCS), a Switzerland-based biopharmaceutical company, is drawing attention in the biotechnology sector with its promising drug pipeline and remarkable potential upside. Despite the..
As Geron Corporation (NASDAQ: GERN) navigates the complex landscape of biotechnology, investors are keenly observing its potential for substantial growth. With a market capitalization of $790.24..
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, is capturing investor attention with a staggering potential upside of 161.84%. With a focus on developing..
GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company based in Dublin, Ireland, has captured investor attention with its intriguing potential upside of 128.01%. Specializing in..
Pharvaris N.V. (NASDAQ: PHVS), a burgeoning force in the biotechnology sector, is capturing investor attention with a standout potential upside of 95.17%, according to the latest..
Cronos Group Inc. (NASDAQ: CRON), a prominent player in the healthcare sector’s specialty and generic drug manufacturing industry, has been attracting investor attention with its robust..
